Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. News
  7. Press Releases
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société RESAPP HEALTH LIMITED
07/05RESAPP HEALTH : Commercial agreement with Doctors on Demand in Australia
PU
06/03RESAPP HEALTH : Medgate extends European ResAppDx trial
PU
05/03RESAPP HEALTH : Agreement secured with Ilara Health to sell ResAppDx in Kenya
PU
04/11RESAPP HEALTH : secures firm commitments to raise $5.5 million
PU
03/24RESAPP HEALTH : TGA clearance achieved for wearable
PU
02/24RESAPP HEALTH : Morgans rates RAP as Add
AQ
2020RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
2017RESAPP HEALTH : Update on Field Evaluation by Médecins Sans Frontières/Doctors W..
PU
2017RESAPP HEALTH : Update on Field Evaluation by Medecins Sans Frontieres
PU
2017RESAPP HEALTH : SMARTCOUGH-C Study and Paediatric Clinical Strategy Update
PU
2017RESAPP HEALTH : Appendix 4E - Preliminary Final Report
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTH : Receives R&D Tax Incentive Cash Refund for FY16
PU
2017RESAPP HEALTH : Reports Preliminary Top-line Results from SMARTCOUGH-C Study for..
PU
2017RESAPP HEALTH : Change of Director's Interest Notice
PU
2017RESAPP HEALTH : Investor Conference Call
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Jun 2017
PU
2017RESAPP HEALTH : Investor Presentation
PU
2017RESAPP HEALTH : Morgans Initiates Research Coverage
PU
2017RESAPP HEALTH : Release of Restricted Securities
PU
2017RESAPP HEALTH : Announces Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : Presentation at ASX Spotlight Investor Conference
PU
2017RESAPP HEALTH : Provides SMARTCOUGH-C May Study Update
PU
2017RESAPP HEALTH : ResAppDx to be Formally Evaluated by Médecins Sans Frontières/Do..
PU
2017RESAPP HEALTH : ResAppDx to be Formally Evaluated by Doctors Without Borders
PU
2017RESAPP HEALTH : Extension of CEO and Managing Director's Contract
PU
2017RESAPP HEALTH : Licenses Additional Pneumonia Diagnostic Tool from UniQuest
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Mar 2017
PU
2017LNK : Change of Perth Address for Shareholder Purposes
PU
2017RESAPP HEALTH : Extends SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : to Present at Upcoming Conferences in March
PU
2017RESAPP HEALTH : Appendix 3B
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Dec 2016
PU
2017RESAPP HEALTH : Announces Expanded Research Collaboration with MGH
PU
2017RESAPP HEALTH : Announces Expanded Research Collaboration with Massachusetts Gen..
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Patersons Securities Initiates Research Coverage
PU
2016RESAPP HEALTH : Receives Institutional Review Board Approval at Texas Children's..
PU
2016RESAPP HEALTH : Receives Institutional Review Board Approval at Massachusetts Ge..
PU
2016RESAPP HEALTH : Change of Director's Interest Notice x 4
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Receives IRB Approval at Massachusetts General
PU
2016RESAPP HEALTH : Confirmation of Change of Auditor
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Sep 2016
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Receives First Institutional Review Board Approval for SMARTCOUG..
PU
2016RESAPP HEALTH : Receives First Institutional Review Board Approval
PU
2016RESAPP HEALTH : Investor Presentation
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Announces Further Positive Results from Adult Clinical Study
PU
2016RESAPP HEALTH : Further Positive Results From Adult Clinical Study
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Change in substantial holding
PU
2016RESAPP HEALTH : Change of Auditor
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Jun 2016
PU
2016RESAPP HEALTH : Bioshares Biotech Summit Presentation
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Update on US Clinical Study
PU
2016RESAPP HEALTH : Positive Preliminary Results from Adult Clinical Study
PU
2016RESAPP HEALTH : Release of Restricted Securities
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Provides Australian Adult Study Enrolment Update
PU
2016RESAPP HEALTH : Appendix 3B - Exercise of Options
PU
2016RESAPP HEALTH : Appendix 3B - Release of Restricted Securities
PU
2016RESAPP HEALTH : Investor Presentation
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Mar 2016
PU
2016RESAPP HEALTH : Appendix 3B and Issue of Cleansing Prospectus
PU
2016RESAPP HEALTH : Completes Oversubscribed $12.5 Million Capital Raising to Expand..
PU
2016RESAPP HEALTH : Completes Oversubscribed $12.5M Capital Raising
PU
2016RESAPP HEALTH : Provides Updated Paediatric Clinical Study Results
PU
2016RESAPP HEALTH : Director Resignation and Appendix 3Z
PU
1  2Next
Upcoming event on RESAPP HEALTH LIMITED
09/01/21